Skip to main content

Skin cancer

Close-up of several glass micropipettes, with long, thin tips, set against a soft, blurred gray background, conveying delicacy and precision.

We have been studying skin cancer for over 20 years, continuously expanding our understanding of the disease in order to bring the best solutions to patients affected by skin cancer.

Challenge

One in three cancers is a skin cancer.

The disease, which comprises many forms, including Melanoma, results in the death of one of five patients diagnosed with the disease. However, there's been significant progress in the diagnosis and treatment of skin cancer driving by an ever-growing understanding of cancer biology.

Stories of

Skin cancer

See more stories

Discover more

Partnering

Innovation

At Roche Partnering, we are passionate about science: yours and ours. Through partnerships, we hope that together we can build a better future with medicines that make a real difference to patients.

Clinical trials

Innovation

Clinical trials are essential to determine whether new drugs or diagnostics are safe and effective when used to diagnose or treat people.